Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin in STEMI Patients Post-PCI
NCT03591991Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Oct 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial in myocardial infarction (MI) comparing Empagliflozin Group with Placebo Group (2 arms). Primary endpoint: Myocardial infarct size at 3 months. Status: unknown.
02
Drugs
empagliflozin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT03591991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03591991.